Uterine Serous Carcinoma clinical trials

Explore recruiting uterine serous carcinoma clinical trials.

Recruiting uterine serous carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Uterine Serous Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 Open-label, multicenter study to evaluate efficacy and safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma

Spain, Italy, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 1/1b Study of BMS-986463 in Advanced Malignant Tumors

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Uterine Serous Carcinoma trials by city

Uterine Serous Carcinoma clinical trials

Recruiting uterine serous carcinoma studies right now

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

Study of EV for Recurrent Endometrial Carcinoma

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma

Azenosertib in Uterine Serous Carcinoma: Biomarker Study

Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma

Also recruiting in Europe

A Phase 2 Open-label, multicenter study to evaluate efficacy and safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma

Phase 1/1b Study of BMS-986463 in Advanced Malignant Tumors

A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors

Uterine Serous Carcinoma trials by city

Other conditions